GLP-1 analogs are more beneficial for type 2 diabetes

04/11/2012 | Medscape (free registration)

Biphasic insulin, basal insulin and glucagon-like peptide 1 analogs control blood glucose levels in people with type 2 diabetes, but GLP-1 analogs also encourage weight loss without raising the risk of hypoglycemia, a meta-analysis found. The results were published in Diabetes, Obesity and Metabolism.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Director of Litigation
Center for Science in the Public Interest
Washington, DC
Health Plan CEO - Oregon
Trillium Community Health Plan
Eugene, OR
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC